vs
Cronos Group Inc.（CRON）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是Cronos Group Inc.的4.9倍（$217.5M vs $44.5M）。Cronos Group Inc.净利率更高（-4.1% vs -20.7%，领先16.6%）。Cronos Group Inc.同比增速更快（47.0% vs 3.1%）。过去两年Cronos Group Inc.的营收复合增速更高（32.7% vs 7.5%）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
CRON vs TLRY — 直观对比
营收规模更大
TLRY
是对方的4.9倍
$44.5M
营收增速更快
CRON
高出43.9%
3.1%
净利率更高
CRON
高出16.6%
-20.7%
两年增速更快
CRON
近两年复合增速
7.5%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $217.5M |
| 净利润 | $-1.8M | $-44.9M |
| 毛利率 | 36.4% | 26.4% |
| 营业利润率 | -16.8% | -10.2% |
| 净利率 | -4.1% | -20.7% |
| 营收同比 | 47.0% | 3.1% |
| 净利润同比 | -104.2% | 47.4% |
| 每股收益（稀释后） | $-0.01 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONTLRY
| Q4 25 | $44.5M | $217.5M | ||
| Q3 25 | $36.3M | $209.5M | ||
| Q2 25 | $33.5M | $224.5M | ||
| Q1 25 | $32.3M | $185.8M | ||
| Q4 24 | $30.3M | $210.9M | ||
| Q3 24 | $34.3M | $200.0M | ||
| Q2 24 | $27.8M | $229.9M | ||
| Q1 24 | $25.3M | $188.3M |
净利润CRONTLRY
| Q4 25 | $-1.8M | $-44.9M | ||
| Q3 25 | $26.0M | $-322.0K | ||
| Q2 25 | $-39.7M | $-1.3B | ||
| Q1 25 | $6.1M | $-789.4M | ||
| Q4 24 | $43.7M | $-85.3M | ||
| Q3 24 | $8.3M | $-39.2M | ||
| Q2 24 | $-8.8M | $-31.7M | ||
| Q1 24 | $-2.2M | $-92.7M |
毛利率CRONTLRY
| Q4 25 | 36.4% | 26.4% | ||
| Q3 25 | 50.4% | 27.4% | ||
| Q2 25 | 43.4% | 30.1% | ||
| Q1 25 | 42.6% | 28.0% | ||
| Q4 24 | 35.7% | 29.0% | ||
| Q3 24 | 10.5% | 29.8% | ||
| Q2 24 | 22.7% | 35.8% | ||
| Q1 24 | 17.7% | 26.2% |
营业利润率CRONTLRY
| Q4 25 | -16.8% | -10.2% | ||
| Q3 25 | -1.4% | 1.0% | ||
| Q2 25 | -15.9% | -643.1% | ||
| Q1 25 | -12.6% | -409.0% | ||
| Q4 24 | -37.5% | -20.0% | ||
| Q3 24 | -98.2% | -18.3% | ||
| Q2 24 | -56.1% | -7.2% | ||
| Q1 24 | -63.1% | -43.6% |
净利率CRONTLRY
| Q4 25 | -4.1% | -20.7% | ||
| Q3 25 | 71.4% | -0.2% | ||
| Q2 25 | -118.7% | -566.9% | ||
| Q1 25 | 19.0% | -424.9% | ||
| Q4 24 | 144.3% | -40.5% | ||
| Q3 24 | 24.4% | -19.6% | ||
| Q2 24 | -31.5% | -13.8% | ||
| Q1 24 | -8.9% | -49.2% |
每股收益（稀释后）CRONTLRY
| Q4 25 | $-0.01 | $-0.41 | ||
| Q3 25 | $0.07 | $0.00 | ||
| Q2 25 | $-0.10 | $7.26 | ||
| Q1 25 | $0.02 | $-8.69 | ||
| Q4 24 | $0.12 | $-0.99 | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $-0.02 | $-0.04 | ||
| Q1 24 | $-0.01 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $1.6B |
| 总资产 | $1.2B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRONTLRY
| Q4 25 | $831.8M | $291.6M | ||
| Q3 25 | $824.2M | $264.8M | ||
| Q2 25 | $834.4M | $256.4M | ||
| Q1 25 | $837.8M | — | ||
| Q4 24 | $858.8M | $252.2M | ||
| Q3 24 | $862.0M | $280.1M | ||
| Q2 24 | $848.2M | $260.5M | ||
| Q1 24 | $855.1M | $225.9M |
股东权益CRONTLRY
| Q4 25 | $1.1B | $1.6B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.1B | $2.7B | ||
| Q4 24 | $1.1B | $3.5B | ||
| Q3 24 | $1.1B | $3.5B | ||
| Q2 24 | $1.1B | $3.4B | ||
| Q1 24 | $1.1B | $3.4B |
总资产CRONTLRY
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | $4.2B | ||
| Q3 24 | $1.2B | $4.3B | ||
| Q2 24 | $1.1B | $4.2B | ||
| Q1 24 | $1.1B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | — |
| 自由现金流率自由现金流/营收 | 21.8% | — |
| 资本支出强度资本支出/营收 | 4.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $149.0K | — |
8季度趋势，按日历期对齐
经营现金流CRONTLRY
| Q4 25 | $11.8M | $-8.5M | ||
| Q3 25 | $13.3M | $-1.3M | ||
| Q2 25 | $2.8M | $-12.8M | ||
| Q1 25 | $-2.1M | $-5.8M | ||
| Q4 24 | $7.7M | $-40.7M | ||
| Q3 24 | $11.6M | $-35.3M | ||
| Q2 24 | $1.7M | $30.7M | ||
| Q1 24 | $-2.2M | $-15.4M |
自由现金流CRONTLRY
| Q4 25 | $9.7M | — | ||
| Q3 25 | $8.8M | — | ||
| Q2 25 | $-1.0M | $-19.1M | ||
| Q1 25 | $-17.4M | $-20.2M | ||
| Q4 24 | $4.2M | $-46.2M | ||
| Q3 24 | $5.2M | $-42.0M | ||
| Q2 24 | $1.0M | $21.0M | ||
| Q1 24 | $-3.9M | $-24.9M |
自由现金流率CRONTLRY
| Q4 25 | 21.8% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | -3.0% | -8.5% | ||
| Q1 25 | -53.8% | -10.9% | ||
| Q4 24 | 13.8% | -21.9% | ||
| Q3 24 | 15.1% | -21.0% | ||
| Q2 24 | 3.7% | 9.1% | ||
| Q1 24 | -15.5% | -13.2% |
资本支出强度CRONTLRY
| Q4 25 | 4.8% | — | ||
| Q3 25 | 12.3% | — | ||
| Q2 25 | 11.5% | 2.8% | ||
| Q1 25 | 47.3% | 7.8% | ||
| Q4 24 | 11.7% | 2.6% | ||
| Q3 24 | 18.7% | 3.4% | ||
| Q2 24 | 2.6% | 4.2% | ||
| Q1 24 | 6.8% | 5.1% |
现金转化率CRONTLRY
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
